Clinical Trial Update: Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describes a study of low-dose short-term ketorolac to reduce chronic opioid use in orthopaedic polytrauma patients. Recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Orthopedic Trauma

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Orthopaedic Trauma, Chronic Opioid Use | Phase 4 | Status: RECRUITING